Which myeloma cells are surviving beyond - HealthTree for Multiple Myeloma
[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Which myeloma cells are surviving beyond chemotherapy? Newer, more sophisticated monitoring to pinpoint surviving cells in order to find better targets with Dr. Bruno Paiva, PhD, University of Navarra

Which myeloma cells are surviving beyond chemotherapy? Newer, more sophisticated monitoring to pinpoint surviving cells in order to find better targets with Dr. Bruno Paiva, PhD, University of Navarra image

Which myeloma cells are surviving beyond chemotherapy? Newer, more sophisticated monitoring to pinpoint surviving cells in order to find better targets with Dr. Bruno Paiva, PhD, University of Navarra

Podcast
event Apr 20, 2015 / 11:00AM MDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

In our fifth MCRI episode featuring the top 10 proposals for high-risk multiple myeloma, Dr. Bruno Paiva describes his study of chemo-resistant myeloma cells after therapy using new, more sensitive minimal residual disease (MRD) monitoring. With the abundance of newer therapies, myeloma doctors have an opportunity to use specific treatments for certain patients, but this requires deeper knowledge about the biology of the tumor cells and better tools to monitor response to treatment. In his study, he aims to answer important questions like: Why do high-risk patients have similar MRD response rates but inferior survival? Why are some patients MRD positive and still have great outcomes? Is it because of the biology of the chemo-resistant cell? Can this information lead to tailored treatment and better survival for high-risk patients? If all patients have several different types of myeloma cells in them at the time of diagnosis, which cells are surviving after high-dose chemo?  In a clinical trial with 100 high-risk patients, he will use the next-generation flow MRD test after chemo to study the tumor cells that remain to hopefully find an attractive target. This is the first time that a newer, more evolved MRD test will not only measure depth of response in a more sensitive way, but also look at the biology of the cells. The Myeloma Crowd Radio Show with Dr. Bruno Paiva, PhD

Schedule & Agenda

Event panelist Dr. Bruno Paiva, PhD and Jenny Ahlstrom
11:00 AM
Discussion
Dr. Bruno Paiva, PhD and Jenny Ahlstrom

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.